Worth Venture Partners’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-657,885
| Closed | -$1.67M | – | 189 |
|
|
2023
Q1 | $1.67M | Sell |
657,885
-364,590
| -36% | -$926K | 0.82% | 34 |
|
|
2022
Q4 | $1.91M | Buy |
1,022,475
+52,777
| +5% | +$98.7K | 1.13% | 29 |
|
|
2022
Q3 | $2.49M | Hold |
969,698
| – | – | 1.53% | 20 |
|
|
2022
Q2 | $2.37M | Buy |
969,698
+185,967
| +24% | +$454K | 1.39% | 22 |
|
|
2022
Q1 | $2.33M | Buy |
783,731
+226,899
| +41% | +$674K | 1.08% | 34 |
|
|
2021
Q4 | $2.5M | Buy |
556,832
+167,392
| +43% | +$752K | 1.24% | 29 |
|
|
2021
Q3 | $1.89M | Buy |
389,440
+158,068
| +68% | +$768K | 0.85% | 41 |
|
|
2021
Q2 | $1.58M | Buy |
231,372
+40,279
| +21% | +$275K | 0.59% | 50 |
|
|
2021
Q1 | $1.35M | Hold |
191,093
| – | – | 0.65% | 45 |
|
|
2020
Q4 | $1.2M | Buy |
191,093
+18,556
| +11% | +$116K | 0.95% | 30 |
|
|
2020
Q3 | $933K | Buy |
+172,537
| New | +$933K | 0.77% | 32 |
|
|
2017
Q2 | – | Sell |
-31,676
| Closed | -$609K | – | 127 |
|
|
2017
Q1 | $609K | Buy |
31,676
+28,736
| +977% | +$552K | 0.54% | 37 |
|
|
2016
Q4 | $45K | Buy |
+2,940
| New | +$45K | 0.05% | 91 |
|